Navigation Links
Novel way to fight cancer

Scientists feel that they have found a innovative way to fight deadly cancers: increase a patient's immune cells in the laboratory to recognize and fight the patient's own tumor, then inject the cells back into the body and let them go to work.//

Known as adoptive transfer, the experimental technique involves the body's T cells, which are responsible for finding and attacking foreign cells that have entered the body. In the experiment, the scientists extracted some of these cells from 15 patients suffering from the deadly form of skin cancer, melanoma, then exposed them in the laboratory to a small segment of the patient's tumor. The cells learned to recognize the tumor fragment as a foreign body and fight it. Additionally the cells also multiplied, providing enough cells to replace the patient's existing immune system, which had proven ineffective at fighting the cancer on its own.

The researchers then used chemotherapy to destroy the patient's ineffective immune system and replaced it with the T cells grown in the laboratory. In 10 of the 16 patients, the treatment resulted in at least a 62 percent shrinkage of the tumors, with no re-growth or appearance of new tumors. Some tumor disappearance was noted in four other patients. The effects lasted for four months, at which time the patient's own immune system recovered and took over its usual job of fighting infections.

The technique, say the investigators, is a major improvement over past attempts to treat cancer with immune cells. Steven A. Rosenberg, M.D., Ph.D., "In the past, only a fraction of a percent of the cells we injected were able to survive, and they would persist for only a few days." In this study, he continues, "We have been able to generate a very large number of immune cells that appear in the blood and constitute a majority of the immune system of the patient. These persist for over four months and are able to attack the tumor."


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel test for bowel cancer
6. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... Bionic Sports Nutrition LLC, an American company ... it had a successful January ECRM Trade Show in Hilton Head, SC. , ... allows it to provide its products to all clients at reasonable prices. At the ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... ... and wellness products to enhance people’s everyday lives, recently attended the January ECRM ... buyers. , ATP Science is known for its large range of supplements that ...
(Date:1/20/2017)... florida (PRWEB) , ... January 20, 2017 , ... Michael ... the Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving ... cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing ... “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, ... , When asked of her new book, Marjorie says, “‘The Angel’ was written as ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
(Date:1/19/2017)... Accuray Incorporated (Nasdaq: ARAY ) ... to set the bar for excellence in customer satisfaction. ... satisfaction rating among radiation treatment delivery systems in the ... Intelligence Briefing™. The most recent ratings trend also shows ... peers for 11 of the past 12 quarters. ...
Breaking Medicine Technology: